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Abstract
The Surviving Sepsis Campaign guidelines for the management of
severe sepsis and septic shock recommend that the initial
hemodynamic resuscitation be done according to the protocol
used by Rivers and colleagues in their well-known early goal-
directed therapy (EGDT) study. However, it may well be that their
patients were much sicker on admission than many other septic
patients. Compared with other populations of septic patients, the
patients of Rivers and colleagues had a higher incidence of severe
comorbidities, a more severe hemodynamic status on admission
(excessively low central venous oxygen saturation [ScvO2], low
central venous pressure [CVP], and high lactate), and higher
mortality rates. Therefore, it may well be that these patients arrived
to the hospital in late untreated hypovolemic sepsis, which may
have been due, in part at least, to low socioeconomic status and
reduced access to health care. The EGDT protocol uses target
values for CVP and ScvO2 to guide hemodynamic management.
However, filling pressures do not reliably predict the response to
fluid administration, while the ScvO2 of septic patients is
characteristically high due to decreased oxygen extraction. For all
these reasons, it seems that the hemodynamic component of the
Surviving Sepsis Campaign guidelines cannot be applied to all
septic patients, particularly those who develop sepsis during their
hospital stay.
Background
The early institution of goal-directed therapy has always been
perceived as a key factor for the successful management of
critically ill patients. In trauma patients, for example, the early
detection of occult hypoperfusion and its correction using
goal-directed therapy have been shown to reduce both
mortality and morbidity [1]. Nevertheless, the 2001 study by
Rivers and colleagues [2] (referred to hereafter as ‘the Rivers
study’) was the first to show that the institution of early goal-
directed therapy (EGDT) upon admission to the emergency
department (ED) can significantly reduce mortality of patients
in severe sepsis or septic shock. The results of the Rivers
study are unique because, due to the complexity of
hemodynamics in sepsis, the goals of therapy are much more
difficult to define with certainty than in other forms of shock
[3]. A recent systematic literature review has indeed found a
lack of agreement on hemodynamic goals for management of
patients with sepsis, proposing that this lack of consistency
may contribute to heterogeneity in treatment effects for
clinical trials of novel sepsis therapies [4]. Although the
challenge of overcoming sepsis has previously prompted the
production of practice parameters for hemodynamic support
of adult septic patients [3], no evidence has been produced,
prior to the Rivers study, that adherence to any such
treatment guidelines can improve the dismal prognosis of
severe sepsis and septic shock.
Following the Rivers study, critical care and infectious
disease experts representing 11 international organizations
developed management guidelines for severe sepsis and
septic shock under the auspices of the Surviving Sepsis
Campaign (SSC) [5]. These guidelines have received world-
wide acclaim for being ‘a noble, well-intentioned approach to
transfer knowledge gained from research into practice at the
bedside’ [6]. The SSC guidelines were adopted by many
medical centers worldwide, a process that is still ongoing and
that has led to numerous reports of improved survival [7]. The
uncontested success of these guidelines has led to their
inclusion in mainstream reviews on the management of sepsis
[8] and made opinion leaders recommend that they be
adopted by the complete health care network involved in the
management of patients with severe sepsis [9].
However, in addition to the recommendations for the initial
hemodynamic resuscitation of the septic patient which are
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based on the Rivers protocol (Table 1), the SSC guidelines
include many other aspects of care, including the early use of
antibiotics, tight glucose control, steroids, recombinant
human-activated protein C, and many more. In the most
recent edition of these guidelines [10], the number of
recommendations increased to 85 from the original 52 that
appeared in the 2004 edition [11]. A close look at all of the
reports of decreasing mortality following the adoption of the
SSC guidelines [7] reveals that, in all of them, all aspects of
the SSC guidelines have been implemented, and not just the
hemodynamic protocol. The reduction in mortality following
the implementation of these guidelines therefore may be
attributed, in part at least, to the early initiation of effective
antimicrobial therapy, which has been shown to play a major
role in sepsis outcome [12]. The growing number of reports
attesting to the success of the SSC guidelines therefore
cannot serve as evidence that the initial hemodynamic
resuscitation ‘bundle’, in and by itself, leads to better survival
[13]. In addition, the Rivers single-center study has never
been repeated and is therefore the only evidence for the
effectiveness of the hemodynamic protocol that is now being
recommended for all hypotensive and/or hyperlactatemic
septic patients, both in and outside the ED. Our reservations
about the inclusion of the Rivers protocol (Table 1) in the
SSC guidelines are based on its perceived physiological
flaws and on the possibility that the patients of the Rivers
study do not represent all septic patients.
Do the Rivers patients represent all septic
patients?
One of the most outstanding findings of the Rivers study is
that the mean central venous oxygen saturation (ScvO2) on
admission to the ED was less than 50% in both the standard
therapy and the EGDT groups [2]. These ScvO2 values are
extremely low since the normal ScvO2 is about 75%.
Moreover, in septic patients, the ScvO2 is mainly normal or
even supranormal due to a reduced oxygen extraction ratio,
which is characteristic of septic shock [14,15]. Recent
studies have indeed found much higher ScvO2 values in
septic shock patients either in the ED or on admission to the
intensive care unit (ICU) [16-18]. In two of these studies
[17,18], the mean ScvO2 was 72% to 74%; in one of them
[18], only 8 out of 125 patients (6%) had an ScvO2 value
below 60% and only 1 patient had an ScvO2 below 50%.
The septic patients in these studies were also different than
the Rivers patients in that the former had lower initial serum
lactate levels [16-18], higher central venous pressure (CVP)
values (10 rather than 5 mm Hg) [18,19], and lower mortality
rates [17-19]. The authors of these recent studies [17-19]
have commented that their septic patients were seemingly
less critically ill at presentation compared with those of Rivers
and colleagues.
What can account for the differences between Rivers’s
patients and these other groups of septic patients? One
suggested hypothesis is that, in the US system, some
patients with sepsis might present much later because of
concern about a lack of health insurance and the associated
cost of care [19]. The Rivers study was done in the ED of an
urban hospital (Henry Ford) in Detroit (MI, USA) and most of
the patients who were included in the study may have come
from a low socioeconomic background. Very recent literature
from the US does emphasize the effects of socioeconomic
conditions on sepsis outcome. African-American patients
were found to be nearly four times more likely to be
uninsured, were more likely to be admitted to the hospital
through the ED and the ICU, and had higher mortality for
sepsis, most probably due to disparities in disease prevention
and care of pre-existing conditions before sepsis onset [20].
Outcome of Americans without insurance who are admitted
to the ICU was found to be worse, possibly because ‘they are
sicker when they seek care’ [21]. Males and African-
Table 1
The Surviving Sepsis Campaign protocol for the initial hemodynamic resuscitation in severe sepsis and septic shock (adopted
from [10])
Begin resuscitation immediately in patients with hypotension or elevated serum lactate of greater than 4 mmol/L, using either crystalloids or
colloids. Give fluid challenges of 1,000 mL of crystalloids or 300 to 500 mL of colloids over the course of 30 minutes. More rapid and larger
volumes may be required in sepsis-induced tissue hypoperfusion.
Resuscitation goals include the following:
Central venous pressure (CVP) of 8 to 12 mm Hg. A higher target CVP of 12 to 15 mm Hg is recommended in the presence of mechanical
ventilation or pre-existing decreased ventricular compliance.
Mean arterial pressure of greater than or equal to 65 mm Hg
Urine output of greater than or equal to 0.5 mL/kg per hour
Central venous (superior vena cava) oxygen saturation (ScvO2) of greater than or equal to 70% or mixed venous oxygen saturation (SvO2) of
greater than or equal to 65%.
If venous O2 saturation target is not achieved, consider further fluid, transfuse packed red blood cells if required to hematocrit of greater than or
equal to 30%, and/or start dobutamine infusion.Page 3 of 5
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Americans were also found to have a greater frequency of
Gram-positive infections, possibly due to specific chronic
comorbid medical conditions [22]. The patients of the Rivers
study indeed seem to have a very high incidence of
significant comorbid conditions. This is evident when these
comorbidities are compared with those that were observed in
the recent CORTICUS (Corticosteroid Therapy of Septic
Shock) study [23], in which all patients had septic shock and
evidence of hypoperfusion or organ dysfunction attributable
to sepsis (Table 2). In addition, alcohol use, which was
reported by nearly 40% of the patients in the Rivers study,
was recently found to be independently associated with
sepsis, septic shock, and hospital mortality among ICU
patients [24].
Recently, it was pointed out that the enrollment of patients
with less severe disease, who are less likely to benefit from a
drug or treatment, may reduce the usefulness of randomized
controlled trial findings for clinical and policy applications
[25]. Similarly, it may well be that Rivers’s patients had a
more severe disease state and a different physiological
profile than other populations of septic patients. Thus, the
combination of significant comorbidities and a more delayed
arrival to the ED of the Rivers patients may have led to a low
cardiac output state and, in turn, to the observed very low
ScvO2 values. One has to note that the use of the word
‘early’ in EGDT refers to the time from the patient’s admission
to the institution of goal-directed therapy and does not
necessarily mean that the sepsis itself is of early onset. This
differentiation is important since septic shock of early onset
was found to be more severe than that of late onset yet was
associated with better outcome [26]. The difference between
early- and late-onset septic shock may therefore influence
clinical trials of therapeutic agents for sepsis and should be
taken into account when analyzing the results of such trials [26].
Are the hemodynamic goals of the Rivers
protocol suitable to guide resuscitation of all
septic patients?
Central venous pressure
The SSC guidelines recommend fluid resuscitation with the
aim of achieving CVP values of 8 to 12 mm Hg as the first
step in the initial hemodynamic management of severe sepsis
or septic shock [10] (Table 1). This recommendation is based
on the practice parameters for hemodynamic support of
sepsis which recommend filling pressures of between 12 and
15 mm Hg for the optimization of cardiac output [3]. These
values originate from a study that was done in 1983 in 15
patients undergoing fluid resuscitation for both hypovolemic
and septic shock [27]. Since then, however, numerous
articles have repeatedly shown that estimates of intravascular
volume based on any given level of filling pressure do not
reliably predict a patient’s response to fluid administration
[28,29]. The 2006 International Consensus Conference on
hemodynamic monitoring in shock also recommended that
preload measurement alone not be used to predict fluid
responsiveness [30]. It did add, however, that low values of
filling pressures should lead to immediate fluid resuscitation
‘with careful monitoring’ and that a fluid challenge should be
done to predict fluid responsiveness with a goal of obtaining
an increase in CVP of at least 2 mm Hg [30]. However, a very
recent study done in septic patients has shown that the
Available online http://ccforum.com/content/12/4/223
Table 2
Comparison of comorbidities of the patients in studies by Rivers and colleagues [2] and Sprung and colleagues (CORTICUS) [23] 
Rivers et al. Sprung  et al. 
(n = 263) (n = 499) Chi-square test
Caucasian (%) Not reported 93
Age (years) 65.7 63
Male/Female (%) 50.6/49.4 66.5/33.5 0.0000
Hypertension (%) 67.3 37.7a 0.0000
Coronary artery disease (%) 25.0 16.9a 0.0080
Congestive heart failure (%) 33.4 6.0a 0.0000
Diabetes (%) 31.4 21.6a 0.0030
Chronic obstructive pulmonary disease (%) 15.7 11.3a 0.0900
Chronic renal failure (%) 21.7 8.7a 0.0000
Liver disease (%) 23.3 8.1a 0.0000
Neurologic disease (%) 33.0 11.7a 0.0000
Cancer (%) 11.4 16.9a 0.0580
Alcohol use (%) 38.6 Not reported
an = 496. CORTICUS, Corticosteroid Therapy of Septic Shock.significance of both CVP and pulmonary artery occlusion
pressure (PAOP) to predict fluid responsiveness was poor
and that a CVP of less than 8 mm Hg and a PAOP of less than
12 mm Hg predicted volume responsiveness with a positive
predictive value of only about 50% [31]. Thus, instituting
aggressive fluid resuscitation in patients with low CVP values
may lead to fluid overload, which may aggravate pulmonary
edema, especially in those patients in whom sepsis is
associated with acute respiratory distress syndrome (ARDS)
and severe pulmonary dysfunction. This is also true for
patients with severe sepsis but without ARDS, of whom more
than half have been found to have increased extravascular
lung water, possibly representing subclinical lung injury [32].
Hence, we can only join Singer’s warning that rapid and large
volume loads may lead to iatrogenic fluid overload and that it
would be more sensible to give guidelines as to when to use
more sophisticated hemodynamic monitoring to better titrate
fluid input, rather than ‘react post-drowning’ [33].
The SSC guidelines go further to recommend that CVP
values of 12 to 15 mm Hg be achieved in mechanically
ventilated patients or patients with increased intra-abdominal
pressure [10] (Table 1). This recommendation is based on a
review article [34] that clearly states, however, that filling
pressures have a low predictive value in estimating fluid
responsiveness during mechanical ventilation and that using
them to guide fluid therapy can lead to inappropriate thera-
peutic decisions. Others recently have claimed that using the
CVP to direct fluid resuscitation of patients with elevated
intra-abdominal or intrathoracic pressure may place the
patient at risk for under-resuscitation with resultant organ
dysfunction and increased mortality [35].
Central venous oxygen saturation
Since the CVP was used as a therapeutic goal in both the
standard therapy and the EGDT groups in the Rivers study,
the use of a target value of 70% for the ScvO2 was, in fact,
the main and only difference in the management of these two
groups [2]. From the Fick formula, it can be derived that the
oxygen extraction ratio is approximately equal to (1 – ScvO2)
[36] and that a low ratio will normally be associated with high
ScvO2 values. This is why the ScvO2 may not be a reliable
parameter to direct therapy in septic patients, since a low
oxygen extraction ratio is characteristic of severe sepsis. The
combination of low oxygen extraction and high ScvO2 was
also demonstrated in other populations of critically ill patients.
Rivers and colleagues [37] have described an impairment of
systemic oxygen utilization in postarrest cardiogenic shock
patients. A similar impairment was found in a group of
patients following cardiac surgery in whom abnormally high
ScvO2 values were associated with increased serum lactate
levels and increased mortality (Perz S, Uhlig S, Reinhart K,
Bauer M, unpublished data).
Further evidence for the fact that the ScvO2 values of Rivers’s
patients are not characteristic of all septic patients can be
found in a later study of Rivers and colleagues [38], in which
patients of both the standard therapy and the EGDT groups
of their original study were combined and then divided into
three resuscitation groups. These included (a) severe global
tissue hypoxia (lactate of greater than or equal to 4 mmol/L
and ScvO2 of less than 70%), (b) moderate global tissue
hypoxia (lactate of greater than or equal to 2 mmol/L and
ScvO2 of less than 70%), and (c) resolved global tissue
hypoxia (lactate of less than or equal to 4 mmol/L and ScvO2
of greater than or equal to 70%) [38]. In a recent multicenter
European study [39], we have found, however, that out of 44
septic patients, 10 (23%) had lactate of greater than or equal
to 2 mmol/L and ScvO2 of greater than 70%, a ‘resuscitation
group’ category that simply does not exist among Rivers’s
patients. These findings are more in line with the recent
reports of significantly higher ScvO2 values [16-18] than
those observed in Rivers’s patients.
Thus, for all clinical purposes, a low ScvO2 value is an
important warning sign of the inadequacy of systemic oxygen
delivery to meet oxygen demands. However, it does not
provide information about the reason for this inadequacy, nor
does it provide guidance as to the optimal therapeutic
approach. On the other hand, a normal or high ScvO2 value
does not rule out persistent tissue hypoxia, especially in
septic patients. Therefore, very often, the ScvO2 value is
unsuitable to guide resuscitation in patients with severe
sepsis or septic shock, especially in the ICU (following
surgery, trauma, ARDS, and so on), where low oxygen
extraction ratios may be more prevalent.
Conclusion
The SSC is one of the most important developments in critical
care in recent years. The people who have put this campaign
together, as well as Rivers and his colleagues whose work
initiated the campaign, should be congratulated for their
immense life-saving contribution. Clearly, septic patients
should be detected and treated as early as possible since they
are at high risk for hemodynamic compromise. Many septic
patients, especially those admitted to the ED, may benefit from
EGDT according to the SSC guidelines, which currently are
being advocated and promoted in the US and internationally in
collaboration with public not-for-profit arbiters of the quality of
health care [40]. However, we join the concerns that some
parts of the ‘bundles’ of care recommended by the SSC have
not been submitted to adequately powered randomized
controlled trials and may actually be ineffective or even harmful
[33]. Basing international treatment guidelines on the Rivers
single-center study would therefore seem premature [41]. This
is especially true in view of the fact that the physiological
variables that are used by the SSC guidelines to direct EGDT
are not suitable for all septic patients and may be misleading
in many instances. We have to wait for the results of the new
ongoing multicenter studies on the initial hemodynamic
management of severe sepsis and septic shock and, until
then, exercise caution.
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